广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2015年
2期
146-149
,共4页
周承新%黄力毅%唐芳%李庆妮%宣伟军
週承新%黃力毅%唐芳%李慶妮%宣偉軍
주승신%황력의%당방%리경니%선위군
白细胞介素-10%基因多态性%乙型肝炎病毒%疾病转归%广西%汉族
白細胞介素-10%基因多態性%乙型肝炎病毒%疾病轉歸%廣西%漢族
백세포개소-10%기인다태성%을형간염병독%질병전귀%엄서%한족
Interleukin-10%Gene polymorphism%Hepatitis B virus%Outcome%Guangxi%Han population
目的:探讨白细胞介素-10(IL-10)基因启动子区-592A/C、-1082G/A位点单核苷酸多态性与乙型肝炎病毒( HBV )易感性及后临床转归之间的关系。方法256例慢性HBV感染者,其中乙型肝炎肝硬化59例,慢性乙型肝炎151例,慢性HBV携带46例,以52例健康体检者作为对照组。采用聚合酶链反应-限制性片段长度多态性分析( PCR-RFLP)技术,检测各组IL-10基因启动子区-592 A/C、-1082 G/A位点基因型及等位基因分布频率。结果肝硬化组、肝炎组、携带组与对照组的IL-10-592A/C 位点 AA、AC、CC 基因型及 A、C 等位基因分布频率比较,差异均无统计学意义(P >0.05);IL-10-1082G/A位点GG、GA和AA基因型分布频率比较,差异有统计学意义(P<0.05),AA基因型频率分布依次为肝硬化组>肝炎组>携带组>对照组(P <0.05);各组 IL-10-1082G/A 位点 G、A 等位基因频率比较,差异有统计学意义(P<0.05),肝硬化组的A等位基因频率分布最高,其余依次为肝炎组、携带组及健康对照组(P<0.05)。不同HBV-DNA水平组的IL-10-592A/C、IL-10-1082G/A两位点基因型及等位基因分布频率比较,差异均无统计学意义( P>0.05)。结论 IL-10-1082G/A位点AA基因型及A等位基因可能与广西汉族人群 HBV 易感性及其临床结局有关;而IL-10基因启动子区-592A/C、-1082G/A位点多态性可能与广西汉族人群感染HBV后的病毒复制水平无明显关系。
目的:探討白細胞介素-10(IL-10)基因啟動子區-592A/C、-1082G/A位點單覈苷痠多態性與乙型肝炎病毒( HBV )易感性及後臨床轉歸之間的關繫。方法256例慢性HBV感染者,其中乙型肝炎肝硬化59例,慢性乙型肝炎151例,慢性HBV攜帶46例,以52例健康體檢者作為對照組。採用聚閤酶鏈反應-限製性片段長度多態性分析( PCR-RFLP)技術,檢測各組IL-10基因啟動子區-592 A/C、-1082 G/A位點基因型及等位基因分佈頻率。結果肝硬化組、肝炎組、攜帶組與對照組的IL-10-592A/C 位點 AA、AC、CC 基因型及 A、C 等位基因分佈頻率比較,差異均無統計學意義(P >0.05);IL-10-1082G/A位點GG、GA和AA基因型分佈頻率比較,差異有統計學意義(P<0.05),AA基因型頻率分佈依次為肝硬化組>肝炎組>攜帶組>對照組(P <0.05);各組 IL-10-1082G/A 位點 G、A 等位基因頻率比較,差異有統計學意義(P<0.05),肝硬化組的A等位基因頻率分佈最高,其餘依次為肝炎組、攜帶組及健康對照組(P<0.05)。不同HBV-DNA水平組的IL-10-592A/C、IL-10-1082G/A兩位點基因型及等位基因分佈頻率比較,差異均無統計學意義( P>0.05)。結論 IL-10-1082G/A位點AA基因型及A等位基因可能與廣西漢族人群 HBV 易感性及其臨床結跼有關;而IL-10基因啟動子區-592A/C、-1082G/A位點多態性可能與廣西漢族人群感染HBV後的病毒複製水平無明顯關繫。
목적:탐토백세포개소-10(IL-10)기인계동자구-592A/C、-1082G/A위점단핵감산다태성여을형간염병독( HBV )역감성급후림상전귀지간적관계。방법256례만성HBV감염자,기중을형간염간경화59례,만성을형간염151례,만성HBV휴대46례,이52례건강체검자작위대조조。채용취합매련반응-한제성편단장도다태성분석( PCR-RFLP)기술,검측각조IL-10기인계동자구-592 A/C、-1082 G/A위점기인형급등위기인분포빈솔。결과간경화조、간염조、휴대조여대조조적IL-10-592A/C 위점 AA、AC、CC 기인형급 A、C 등위기인분포빈솔비교,차이균무통계학의의(P >0.05);IL-10-1082G/A위점GG、GA화AA기인형분포빈솔비교,차이유통계학의의(P<0.05),AA기인형빈솔분포의차위간경화조>간염조>휴대조>대조조(P <0.05);각조 IL-10-1082G/A 위점 G、A 등위기인빈솔비교,차이유통계학의의(P<0.05),간경화조적A등위기인빈솔분포최고,기여의차위간염조、휴대조급건강대조조(P<0.05)。불동HBV-DNA수평조적IL-10-592A/C、IL-10-1082G/A량위점기인형급등위기인분포빈솔비교,차이균무통계학의의( P>0.05)。결론 IL-10-1082G/A위점AA기인형급A등위기인가능여엄서한족인군 HBV 역감성급기림상결국유관;이IL-10기인계동자구-592A/C、-1082G/A위점다태성가능여엄서한족인군감염HBV후적병독복제수평무명현관계。
Objective To explore the relationship of single nucleotide polymorphism ( SNP ) of interleukin-10 ( IL-10 ) gene promoter-592A/C and -1082G/A with susceptibility of hepatitis B virus (HBV) infection and its clinical outcome .Methods Polymerase chain reaction-restriction fragment length polymorphism ( PCR-RFLP) assay was used to determine the distribution frequencies of genotype and allele of IL-10-592A/C and -1082G/A among 256 cases of chronic HBV infection,including 59 cases of liver cirrhosis(LC),151 cases of chronic hepatitis B(CHB) and 46 cases of chronic asymptomatic HBV carrier (ASC),as well as among 52 healthy controls. Results There was no significant difference in genotype AA , AC and CC frequencies of IL-10-592A/C in each chronic HBV group compared with healthy controls,as well as allele A and C frequencies(P>0.05).There was significant difference in genotype GG ,GA and AA frequencies of IL-10-1082G/A in each chronic HBV group compared with healthy controls,as well as allele G and A frequencies(P<0.05), and the genotype AA and allele A frequencies of IL-10-1082G/A were significantly higher in LC patients than those in CHB patients,ASC patients and healthy controls( P<0.05).No significant difference was found in frequencies of genotypes and alleles of IL-10-592 A/C and IL-10-1082G/A between HBV-DNA<1.0 ×103 copies/ml group and HBV-DNA >1.0 ×103 copies/ml group(P >0.05).Conclusion IL-10-1082G/A genotype AA and allele A might be associated with the susceptibility of HBV infection and its clinical outcome in Guangxi Han population.The gene polymorphisms of IL-10 promoter-592A/C and-1082G/A might not be significantly associated with HBV-DNA replication after being infected with HBV in Guangxi Han population.